Outset Medical(OM)
Search documents
Outset Medical (OM) Receives Nasdaq Notice, Shares No Longer Meet Minimum Bid Requirement, Class Action Pending After FDA Warning - Hagens Berman
GlobeNewswire News Room· 2024-10-01 18:27
SAN FRANCISCO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Hagens Berman encourages Outset Medical (NASDAQ: OM) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may assist the investigation to contact its attorneys. On September 27, 2024, Outset Medical announced that it received notice from the Listing Qualifications staff of Nasdaq that "because the closing bid price for the Company's common stock had fallen below $1.00 per share for 30 consecu ...
Investors who lost money on Outset Medical, Inc. (OM) should contact The Gross Law Firm about pending Class Action - OM
GlobeNewswire News Room· 2024-09-24 17:08
NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Outset Medical, Inc. (NASDAQ: OM). Shareholders who purchased shares of OM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/outset-medical-loss-submission-form/?id=104530&from=3 CLASS PERIOD: August 1, 20 ...
Class Action Filed Against Outset Medical, Inc. (OM) - October 28, 2024 Deadline to Join - Contact The Gross Law Firm
Prnewswire· 2024-09-23 09:45
NEW YORK, Sept. 23, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Outset Medical, Inc. (NASDAQ: OM). Shareholders who purchased shares of OM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/outset-medical-loss-submission-form/?id=104038&from=4 CLASS PERIOD: August 1, 2022 t ...
Investors who lost money on Outset Medical, Inc. (OM) should contact Levi & Korsinsky about pending Class Action - OM
GlobeNewswire News Room· 2024-09-19 17:37
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ: OM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Outset Medical investors who were adversely affected by alleged securities fraud between August 1, 2022 and August 7, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/outset-medic ...
Shareholders that lost money on Outset Medical, Inc.(OM) should contact The Gross Law Firm about pending Class Action - OM
Prnewswire· 2024-09-19 09:45
NEW YORK, Sept. 19, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Outset Medical, Inc. (NASDAQ: OM). Shareholders who purchased shares of OM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/outset-medical-loss-submission-form/?id=103512&from=4 CLASS PERIOD: August 1, 2022 t ...
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Outset Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OM
GlobeNewswire News Room· 2024-09-18 20:40
NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outset Medical, Inc. (NASDAQ: OM) between August 1, 2022 and August 7, 2024, both dates inclusive (the "Class Period"), of the important October 28, 2024 lead plaintiff deadline. SO WHAT: If you purchased Outset Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrange ...
Shareholders of Outset Medical, Inc. Should Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights – OM
GlobeNewswire News Room· 2024-09-18 17:36
Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Outset Medical, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions related to the company's Tablo products used in dialysis care [1][2]. Summary by Sections Class Period and Allegations - The class period for the lawsuit is from August 1, 2022, to August 7, 2024 [2]. - Allegations include that Outset Medical marketed its Tablo products for uses not approved by the FDA, which could lead to a need for additional regulatory applications [2]. - There is a substantial risk that the company may have to cease sales of Tablo products pending FDA approval for additional indications [2]. - The company reportedly lacked the necessary sales team and processes to effectively ramp up Tablo sales, which would adversely impact revenue growth [2]. - Positive statements made by the defendants regarding the company's business and prospects were claimed to be materially misleading [2]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by the deadline of October 28, 2024, to potentially become lead plaintiffs [3]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle [3]. About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].
OM CLASS ACTION: Outset Medical, Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit
GlobeNewswire News Room· 2024-09-17 22:10
SAN DIEGO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Outset Medical, Inc. (NASDAQ: OM) securities between August 1, 2022 and August 7, 2024. Outset Medical is a medical technology company. Its primary products are the Tablo series devices used in dialysis care, including the Tablo Hemodialysis System and the TabloCart. For more information, submit a form, email attorney A ...
Outset Medical, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM
Prnewswire· 2024-09-17 09:45
NEW YORK, Sept. 17, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ: OM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Outset Medical investors who were adversely affected by alleged securities fraud between August 1, 2022 and August 7, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/outset-medical-l ...
October 28, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against OM
Prnewswire· 2024-09-16 09:45
NEW YORK, Sept. 16, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Outset Medical, Inc. (NASDAQ: OM). Shareholders who purchased shares of OM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/outset-medical-loss-submission-form/?id=102423&from=4 CLASS PERIOD: August 1, 2022 t ...